LIO-1: Initial phase 2 experience with lucitanib plus nivolumab in patients with persistent or recurrent cervical cancer (NCT04042116; ENGOT-GYN3/AGO/LIO) Meeting Abstract


Authors: Heitz, F.; Oaknin, A.; Backes, F. J.; Van Nieuwenhuysen, E.; Eskander, R. N.; González-Martín, A.; Makker, V.; Marth, C.; Patel, M.; Penson, R. T.; Redondo, A.; Pérez, M. J. R.; Hamilton, E.; Wimberger, P.; Concin, N.; Go, J.; Wride, K.; Lepley, D.; Dusek, R.; Cameron, T.; Pignata, S.
Abstract Title: LIO-1: Initial phase 2 experience with lucitanib plus nivolumab in patients with persistent or recurrent cervical cancer (NCT04042116; ENGOT-GYN3/AGO/LIO)
Meeting Title: 64th Kongress der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG)
Journal Title: Geburtshilfe und Frauenheilkunde
Volume: 82
Issue: 10
Meeting Dates: 2022 Oct 12-15
Meeting Location: Munich, Germany
ISSN: 0016-5751
Publisher: Georg Thieme Verlag Kg  
Date Published: 2022-10-01
Start Page: e87
End Page: e88
Language: German
ACCESSION: WOS:000867683500137
DOI: 10.1055/s-0042-1756856
PROVIDER: wos
Notes: Meeting Abstract: 136 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vicky Makker
    263 Makker